Member Info for Jacobjohn7

And one Million the other day. We need em out they're not my fave people after half a year destruction of shareholder value

At this price they may even just be being taken by mm

At this price they may even just be being taken by mm

Be interesting to see if they go nukems way or just go. As that's been another 2.3m

So obvious there was large sell in the background as we should have moved up yesterday otherwise. . How many more do atami hold it it them. Get them out completely as that's the

Major reason for weighing on the sp

The whole Oxford and others study is looking at gas exchange so presume that's all supportive. Amongst other studies elsewhere.

I'm wondering where we are on the explain study or others conducted with Oxford University hospital? Got to be something pending from that and will some of this study and others be supporting the gas exchange fda application? Has the fda route started yet? Or is that scheduled in via a partnership to fund this progress?

Some buy volume being demonstrated this morning!

Please elaborate.

Buy or sell. Amati finishing off ? Wondered why had gone back up with the buys since yesterday's dip

The old saying they take a lift down and the stairs up

Another decent volume day . And they overdone it ... should be ticking back up soon.

Think the trading within the spread I think makes the 4.81 a buy.

As expected. With the spread almost impossible to short term trade without news. Once out its difficult to get a buy at the previous sell price. Sit tight wait for more support or more support via News of a trial conversion or other

**** trump. keep this polarean not politics.

Fwiw we are a buy now on British bulls.

It all helps

https://www.britishbulls.com/SignalPage.aspx?lang=en&Ticker=POLX.L

That would be a welcome avenue Philips and bracco are very supportive .. they will have their reasons

The 5.35 trades are buys they will a large amount off me no questions asked. Depends what the offers are on level 2. Just try to get a fair idea of trades when they try to fudge it

A partnership initially for europe and uk with bracco makes an incredible amount of sense. Easy one to announce and back in double figures easy. The 3 very close trial conversions any time literally now. I'm surprised duke not been shoe horned in yet. Always ongoing chance of other de novo clients . And the fact that Phillips and polarean are discussing in unison is pretty awesome for a currently 10m company! With fda clearance. Health code scope due to increase and fda coverage due to increase. Its a glaring undervalued gem. Just needs a little polish. I'm incredibly happy with von jako at the helm so absolutely confident .

A partner can concentrate on the other regions for him/us